OpenAI has just unveiled their first biological AI model that could revolutionize how we approach aging and longevity.
In collaboration with Retro Biosciences, this groundbreaking technology makes stem cell production 50 times more efficient than current methods.
🔍 In this video, we explore:
How GPT-4b micro works with Yamanaka factors
Sam Altman's $555M investment in life extension
The connection between OpenAI and Retro Biosciences
Why this could be a game-changer for regenerative medicine
The potential impact on human lifespan
⚡️ Key highlights:
First-ever biological AI model from OpenAI
Trained on multi-species protein sequences
Could extend human lifespan by 10 years
Represents OpenAI's entry into scientific discovery
Potential applications in organ replacement and disease treatment
🔗 Sources mentioned:
MIT Technology Review: https://www.technologyreview.com/2025...
TechCrunch: https://techcrunch.com/2025/01/17/ope...
💭 What are your thoughts on using AI to extend human lifespan? Share in the comments below!
⚡️ Want to learn how to leverage AI in your business? Ready to become a First Mover? Visit firstmovers.ai and fill out the form to request your free AI discovery analysis call with our expert team. Learn how to build true first mover's advantage in your business.
.........................................................................................
Follow me on X: / juliaemccoy
→ Want to revolutionize your company with AI? Book a discovery call with First Movers to see how we can help you grow with custom AI solutions. https://firstmovers.ai
→ Own your AI future. Join First Movers AI R&D AI Labs to transform your skillsets and become AI-ready with our proven AI frameworks and automation strategies. Get on the waitlist now: firstmovers.ai/labs [launching Q1 2025]
→ Subscribe to my channel for more AI insights: / juliamccoy
→ Listen to my podcast, Leaders of AI: / @leadersofaipodcast